• What We Do
  • Technology
  • Products
  • Partnerships

Management team

  • Mr. Ofer Haviv
    Mr. Ofer Haviv
    President and Chief Executive Officer

    Ofer Haviv holds the position of Evogene's President and CEO as of late 2004. Prior to that he held the positions of company COO and CFO from 2002 to 2004 and was involved in Evogene's spin-off from Compugen in 2002. At Compugen, he held the position of Director of Finance and Treasurer of Compugen (NASDAQ: CGEN) for four years, during which time the company completed two private placements and an IPO on NASDAQ

    Mr. Haviv holds a B.A. degree in Economics and Accounting from Faculty of Management, Tel Aviv University and is a Certified Public Accountant in Israel.

  • Dr. Hagai Karchi
    Dr. Hagai Karchi
    Chief Technology Officer and Head of R&D Crop Enhancement

    Dr. Karchi is co-founder of Evogene and served as its CEO from 2002 to 2004. Prior to the spin-off of Evogene from Compugen he was the Co-Head of Compugen's Plant Genomic Division. He has over 15 years experience in the breeding of tomatoes and in molecular genomics research. His scientific achievements include the development of a molecular system for gene discovery and the development of high yielding, high quality greenhouse tomato varieties. Dr. Karchi has lectured widely in the field of plant genomics and has an extensive record of publications and patents.

    Dr. Karchi holds B.Sc and M.Sc degrees from the Hebrew University of Jerusalemױs Faculty of Agriculture, specializing in gene expression. He holds a Ph.D. from The Weizmann Institute of Science and the Hebrew University of Jerusalem, Israel.

  • Mr. Assaf Oron
    Mr. Assaf Oron
    Executive Vice President Corporate Development

    Assaf joined Evogene in 2006 and  since then led the company's business development and strategy efforts. In 2015 Assaf was appointed as Executive Vice President Corporate Development. Prior to joining Evogene, Assaf was CEO of ChondroSite, a biotechnology company that develops tissue engineered products in the field of orthopedics. Prior to ChondroSite, Assaf worked at Glenrock, a private investment company, overseeing various biotechnology related ventures, and led several strategic consulting roles at POC, a leading Israeli management consulting firm.

    Assaf holds an M.Sc. degree in Biology and a B.Sc. degree in Economics and Chemistry from Tel Aviv University.

  • Mr. Assaf Kacen
    Mr. Assaf Kacen
    Chief Operation Officer

    Mr. Kacen leads Evogene’s Technology Platform,  overseeing the company’s core R&D, field and greenhouse experiments, computational genomics and data management platforms,  plant research laboratories and high-throughput validation systems, all of which form the implementation  layer of the company’s research and development programs. Prior to joining  Evogene, Mr.  Kacen held senior product management positions at Nokia Siemens Networks where he gained substantial R&D management experience leading multi-disciplinary teams across several broad scope projects.

    Mr. Kacen holds an MBA from Interdisciplinary Center, Herzlia, majoring in Finance, and a B.Sc in Communication Systems Engineering from Ben-Gurion University. 

  • Ms. Sigal Fattal
    Ms. Sigal Fattal
    Chief Financial Officer

    Ms. Fattal has over 16 years of experience at the Financial Sector, mainly with Blue Chip International and public companies. Prior to joining Evogene, during the years 2011-2012, Ms. Fattal served as the CEO of wwCFO Ltd., prior to that during the years 2008-2010, Ms. Fattal held the position of CFO and VP Business Development of Cal International.

    Ms. Fattal holds a B.A. in accounting and economics, with honors, and a MBA specializing in finance and marketing, both from Tel Aviv university.

  • Dr. Eyal Emmanuel
    Dr. Eyal Emmanuel
    Chief Science Officer and Head of R&D Crop Protection

    Dr. Emmanuel joined Evogene in May 2006, and since that time has held various R&D management positions at the Company, most recently as Vice President R&D of the Company’s Ag-Chemicals division. Prior to joining Evogene, Dr. Emmanuel served as a researcher at Life Science Research Israel, Israel’s premier life sciences research center.

    Dr. Emmanuel holds a B.Sc. from the Hebrew University, Faculty of Agriculture and an M.Sc.and  Ph.D from the Weizmann Institute of Science. Dr. Emmanuel also holds an MBA, from the College of Management in Israel, majoring in Bio-Medical Management.

  • Mr. Ido Dor
    Mr. Ido Dor
    Executive Vice President & General Manager Crop Enhancement

    Ido was appointed as Executive Vice President & General Manager Crop Enhancement in November 2015. Mr. Dor joined Evogene in 2011 as a Director of Business Development and led the business activity of the Ag Chemicals division. Since 2015 he is leading Evogene’s Ag Biologicals activity, overseeing research, development and business aspects. Prior to joining Evogene, Ido headed the Israeli Small & Mid-Size Enterprise business activity at SAP, the world leading organizational software company. Prior to his role at SAP, Ido led a business unit at Niram Gitan Group, a leading Israeli management-consulting firm.

    Mr. Dor holds an MBA degree and a B.Sc. degree in Industrial Engineering - both from Tel Aviv University.

  • Mr. Eran Kosover
    Mr. Eran Kosover
    Executive Vice President & General Manager Crop Protection

    Mr. Kosover was appointed as Executive Vice President & General Manager Crop Protection in November 2015.Prior to this position, Mr. Kosover served as Evogene’s VP Project Management, where his team was in charge of managing all collaborations and internal projects in the company, and prior to that as a Business Development Manager in Evogene. Prior to Evogene, Mr. Kosover was in charge of Sales, Business Development and Operations in Atera, an Israeli Hi-tech start-up in the field of SMB IT. Prior to Atera, Mr. Kosover worked as a Project Manager in various Strategic Consulting projects for Teva Pharmaceuticals.

    Mr. Kosover holds an M.A. in Economics from the Tel Aviv University Berglas School of Economics (2006); and a B.A. in Economics and Management from the Tel Aviv University (2002).